Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil for emergence agitation in laparoscopic cholecystectomy
ChiCTR2400080995Phase 4Not yet recruiting
- Sponsor
- Weihai Municipal Hospital
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in cholecystitis, cholelithiasis and gallbladder polyp (2 arms), sponsored by Weihai Municipal Hospital. Primary endpoint: Awakening restlessness level. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
remifentanil
03
Conditions
cholecystitischolelithiasisgallbladder polyp
Beyond the preview
Go deeper on ChiCTR2400080995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080995.